Last reviewed · How we verify

Prevention of Premature Labor — Treatment Landscape & Competitive Intelligence

Prevention of Premature Labor (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of Premature Labor, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Antocin Ii ATOSIBAN Ferring Pharmaceuticals A/S atosiban Vasopressin V1a receptor 2000-01-01
Delalutin HYDROXYPROGESTERONE CAPROATE Bristol-Myers Squibb Progestin Corticosteroid-binding globulin 1975-01-01
Endometrin progesterone Ferring Progesterone [EPC] Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1
Progesteron Progesteron Minia University Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Bristol-Myers Squibb · 1 drug in Prevention of Premature Labor
  2. Ferring · 1 drug in Prevention of Premature Labor
  3. Ferring Pharmaceuticals A/S · 1 drug in Prevention of Premature Labor
  4. Minia University · 1 drug in Prevention of Premature Labor

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of Premature Labor:

Cite this brief

Drug Landscape (2026). Prevention of Premature Labor — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-premature-labor. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing